Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Insulin glargine biosimilar - Boehringer Ingelheim/Eli Lilly and Company

Next Previous
X
Search
Drug Profile

Insulin glargine biosimilar - Boehringer Ingelheim/Eli Lilly and Company

Alternative Names: Abasaglar; Abasria; Basaglar; LY-2963016; LY2963016 U-100; LY2963016 U-200

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Eli Lilly and Company
  • Developer Boehringer Ingelheim; Eli Lilly and Company
  • Class Antihyperglycaemics; Insulins; Pancreatic hormones
  • Mechanism of Action Insulin receptor agonists; Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • No development reported Diabetes mellitus

Most Recent Events

  • 28 Feb 2023 No recent reports of development identified for phase-I development in Diabetes-mellitus(In volunteers) in China (SC)
  • 21 Sep 2020 Pharmacokinetics, pharmacodynamics and safety results from a phase I trial for Diabetes mellitus presented at the 56th Annual Meeting of the European Association for the Study of Diabetes Session (EASD-2020)
  • 28 Apr 2020 Eli Lilly and Company completes a phase III clinical trial in Type-2 diabetes mellitus (Adjunctive treatment) in China (SC) (NCT03338010)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top